Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Comment by Aarcoron Jun 26, 2022 11:48am
115 Views
Post# 34783055

RE:RE:RE:RE:RE:Bioasis Connections

RE:RE:RE:RE:RE:Bioasis Connections
KayakerBC wrote: This post of Aarcor's is one of the most refreshing posts I've read in a while.

Uh huh.  More whining and complaining about the past 10 years.  As if any of that is the fault of the current CEO.  Like any of it sounds better the 47th time I've heard it.  

And this fantasy that if we could just get rid of the current CEO and board everything would be sooooooooooooo much better.  I'm sure we'd be brimming with cash, the stock would be bumping into 5 bucks, and we'd be starting multiple clinical trials any flippin day now.  Or just maybe a new CEO and board would be entirely focused on lining their own pockets and screwing current stock holders.



Here's BCYakker weighing in again.

He has a few general themes that he has gone on about for 10 years as well.

He likes to talk about what a bad deal current management has inherited and therefore, we can't expect much.  That's nice, no accountability for the healthy 6 figure part-time salary Rathjen is drawing from the other side of the world.  A positive change is a "fantasy" and for the worse since new management would be "screwing current shareholders".  Free pass.

He likes to tell shareholders that have invested in BTI based on management promises of xb3-001 to the clinic to stop whining and sell at all-time lows.  Free pass.

He likes to talk about ridiculous multi-year/decade timelines being acceptable because "things take longer than expected", often throwing in links explaining the human fallacy of mismanaging project delivery.  Mind-bending critical thinking.  Free pass to 2034.

He points out he is continually buying stock in this company because there is large upside, despite "strategic alternatives" under way, none of which he knows anything about at the moment.  Seems smart and well reasoned.  Free pass.

Steadfastly stupid.  It's tiring to listen to. 
<< Previous
Bullboard Posts
Next >>